Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT03196427
Previous Study | Return to List | Next Study

Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03196427
Recruitment Status : Active, not recruiting
First Posted : June 22, 2017
Last Update Posted : January 8, 2021
Sponsor:
Collaborators:
Takeda Development Center Americas, Inc.
Takeda Development Centre Europe Ltd.
Information provided by (Responsible Party):
Takeda

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : May 25, 2025
Estimated Study Completion Date : May 25, 2025